US Edition
LVHN to pay feds $2.7 million to settle allegations of mishandling controlled substances
- Lehigh Valley Health Network agreed on July 2, 2025, to pay $2.75 million to resolve allegations of controlled substance theft at its Cedar Crest pharmacy in Pennsylvania.
- The settlement followed disclosures that a pharmacy technician used another employee's password on about 40 occasions to divert drugs and created false reports to conceal the thefts.
- The allegations claim LVHN failed to maintain accurate records and adequate controls, including improper transfers of substances between inpatient and outpatient locations, but cooperated with federal authorities to improve compliance.
- U.S. Attorney David Metcalf clarified that the settlement addresses allegations without an admission of liability, while DEA Special Agent Thomas Hodnett highlighted that the agreement reflects a dedication to maintaining rigorous standards and ensuring public safety.
- The settlement highlights ongoing federal efforts to hold healthcare providers accountable amid the opioid crisis and recognizes LVHN's cooperation and resource investments to strengthen controlled substance security.
12 Articles
12 Articles
LVHN to pay $2.7M amid allegations it didn't do enough to prevent drug thefts
The Lehigh Valley Health Network will pay nearly $3 million to resolve allegations that claimed it didn't do enough to prevent the theft of controlled substances at its facilities.
LVHN to pay feds $2.7 million to settle allegations of mishandling drugs that went missing
Lehigh Valley Health Network has agreed to pay $2.75 million to the federal government in a settlement after an employee stole controlled substances from Lehigh Valley Hospital-Cedar Crest.
readingeagle
The Pottstown MercuryLVHN to pay feds $2.7 million to settle allegations of mishandling controlled substances
Lehigh Valley Health Network has agreed to pay $2.75 million to the federal government after an employee stole controlled substances from Lehigh Valley Hospital-Cedar Crest. U.S. Attorney David Metcalf announced Wednesday that LVHN was paying the settlement to resolve allegations that it failed to comply with provisions of the Controlled Substances Act that are designed to prevent controlled substances from being diverted for illegal uses. It al…
Tioga Publishing
LVHN pays $2 million settlement for CSA non-compliance involving pharmacy technician misconduct
Lehigh Valley Hospital Network, Inc. (LVHN) has agreed to pay over $2 million to resolve allegations that it failed to comply with provisions of the Controlled Substances Act (CSA), according to an attorney on Wednesday.
Lehigh Valley Health Network to Pay $2.75 Million to Resolve Allegations of Controlled Substance Failures
PHILADELPHIA, PA — Lehigh Valley Hospital Network, Inc. (LVHN) has agreed to pay $2.75 million to settle allegations that it failed to adhere to critical safeguards under the Controlled Substances Act (CSA), according to an announcement from United States Attorney David Metcalf. The settlement addresses serious compliance failures, including multiple incidents of drug diversion at LVHN’s Cedar Crest pharmacy. Federal authorities allege that on a…
Coverage Details
Bias Distribution
- 63% of the sources are Center
To view factuality data please Upgrade to Premium
